News – Page 630 – Endpoints News

As flu season emerges, BD completes syringe manufacturing lines with help from US government; Hot off summertime ...

4 years ago

Biden likely to nominate Verily's Rob Califf to lead the FDA again

4 years ago

This midwestern CDMO just picked up 3 acquisitions in less than a week

4 years ago

Six years and nearly $1B later, Boehringer Ingelheim's largest ever investment is now operational

4 years ago

A star Stanford professor leaves his lab for a startup out to remake psychiatry

4 years ago

AstraZeneca oncology R&D chief Susan Galbraith: 'You're going to need orthogonal combinations'

4 years ago

Novartis' discovery team hires Genentech vet Shiva Malek to lead early-stage oncology work

4 years ago

Exelixis, Storm join up in collaboration and license agreement; Teligent files for bankruptcy

4 years ago

In the packed oncolytic virus space, a German biotech with a unique approach makes investors reach deeper into their ...

4 years ago

A California biotech steps into the viral vector space with new site build of $75M

4 years ago

Bristol Myers wants to pull out of its Abraxane deal in China. BeiGene says no way

4 years ago

Covid-19 roundup: Regeneron nabs priority review for mAb; Preprint suggests mixing boosters is safe ahead of adcomms

4 years ago

Broad Institute hires René Salazar to tackle biomedical research's diversity problem

4 years ago

Atlas backs a longtime Vertex employee’s quest to bring CF success to numerous other diseases

4 years ago

Biden's fight with Moderna over providing vaccines for the poorest countries intensifies

4 years ago

Merck carves out path in first-line advanced cervical cancer with new FDA win for Keytruda juggernaut

4 years ago

FDA+ roundup: Marks on Woodcock's tenure as acting commissioner; FDA leaders offer perspective on barriers to ...

4 years ago

Big Pharma companies join hands with Amazon on new Israel-based AI incubator

4 years ago

Regulus dumps first-gen ADPKD treatment in favor of second iteration; Sutro joins BioNova in $200M deal

4 years ago

Charles River Laboratories has been on an acquisition spree. But Tuesday, it offloaded two assets

4 years ago

Spurned by the FDA, Ardelyx execs grab bonuses to stay on while axing nearly two-thirds of remaining staff

4 years ago

Eli Lilly bags FDA nod for Verzenio in early breast cancer, but a controversial diagnostic could dog its rollout

4 years ago

J&J proposes sliding booster timelines as FDA questions lack of data for Delta, older adults before adcomm

4 years ago

Drawn to the idea of turning B cells into 'protein factories,' Takeda jumps into a milestone-heavy, $900M pact

4 years ago

First page Previous page 627 628 629630631 632 633 Next page Last page